Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
187 patents granted to the 24 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Bausch Health Companies Inc’s names, not what it holds today.
Patents granted
187
174 utility, 13 design, 1976 to Dec 31, 2025
Granted in 2025
5
Against 14 in 2024 and 14 in 2023
Applications published
292
9 of them in 2025
Names they are printed under
24
a subsidiary, a former name, its own name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals30
Medical technology10
Biotechnology4
Organic fine chemistry1
Computer technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name24 counted
Salix Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
63 granted
48 publishedBausch Health Ireland Limited a subsidiary
named as the applicant on its applications, in IE
0 granted
63 publishedSalix Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
56 publishedBausch Health Ireland Limited a subsidiary
IE, as the owner printed on each patent
42 granted
7 publishedValeant Pharmaceuticals International, Inc. a former name
US, as the owner printed on each patent
23 granted
13 publishedSantarus, Inc. a subsidiary
US, as the owner printed on each patent
7 granted
24 publishedPrecision Dermatology, Inc. a subsidiary
US, as the owner printed on each patent
11 granted
17 publishedSolta Medical, Inc. a subsidiary
US, as the owner printed on each patent
10 granted
17 publishedOrapharma, Inc. a subsidiary
US, as the owner printed on each patent
12 granted
7 publishedMedicis Pharmaceutical Corporation a subsidiary
named as the applicant on its applications, in US
0 granted
14 publishedSolta Medical Ireland Limited a subsidiary
IE, as the owner printed on each patent
12 granted
0 publishedValeant Pharmaceuticals International, Inc. a former name
named as the applicant on its applications, in US
0 granted
6 publishedSantarus, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
5 publishedSolta Medical, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
5 publishedBausch Health US, LLC a subsidiary
named as the applicant on its applications, in US
0 granted
4 publishedPrecision Dermatology, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
3 publishedBAUSCH HEALTH US, LLC a subsidiary
US, as the owner printed on each patent
2 granted
0 publishedSOLTA MEDICAL IRELAND LIMITED a subsidiary
named as the applicant on its applications, in IE
0 granted
2 publishedBAUSCH HEALTH COMPANIES INC. its own name
CA, as the owner printed on each patent
1 granted
0 publishedBausch Health Americas, Inc. a subsidiary
US, as the owner printed on each patent
1 granted
0 publishedBausch Health Companies Inc. its own name
named as the applicant on its applications, in CA
0 granted
1 publishedBiovail Corporation a former name
CA, as the owner printed on each patent. 1 more under the same name are not counted (printed in FR)
1 granted
0 publishedBiovail Corporation International a former name
CA, as the owner printed on each patent
1 granted
0 publishedHUMAX PHARMACEUTICAL S.A. a subsidiary
CO, as the owner printed on each patent
1 granted
0 published
Names not counted (24)
Bausch + Lomb Corporation
Counted on the file of Bausch & Lomb Corp, whose own name it is. 1,104 granted and 197 published under it are not counted.
Bausch + Lomb Corporation
Counted on the file of Bausch & Lomb Corp, whose own name it is. 0 granted and 80 published under it are not counted.
Synergetics, Inc.
Also listed as a subsidiary by Bausch & Lomb Corp. 52 granted and 23 published under it are not counted.
Bausch + Lomb Ireland Limited
Also listed as a subsidiary by Bausch & Lomb Corp. 0 granted and 68 published under it are not counted.
AcuFocus, Inc.
Also listed as a subsidiary by Bausch & Lomb Corp. 42 granted and 12 published under it are not counted.
Bausch + Lomb Ireland Limited
Also listed as a subsidiary by Bausch & Lomb Corp. 34 granted and 14 published under it are not counted.
Technolas Perfect Vision GmbH
Also listed as a subsidiary by Bausch & Lomb Corp. 41 granted and 4 published under it are not counted.
AcuFocus, Inc.
Also listed as a subsidiary by Bausch & Lomb Corp. 0 granted and 35 published under it are not counted.
ELIOS Vision GmbH
Also listed as a subsidiary by Bausch & Lomb Corp. 17 granted and 16 published under it are not counted.
ELIOS Vision GmbH
Also listed as a subsidiary by Bausch & Lomb Corp. 0 granted and 21 published under it are not counted.
Synergetics, Inc.
Also listed as a subsidiary by Bausch & Lomb Corp. 0 granted and 18 published under it are not counted.
Kedalion Therapeutics, Inc.
Also listed as a subsidiary by Bausch & Lomb Corp. 0 granted and 15 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Sep 30, 2025 | 12,426,940 | Electrode assemblies with non-contact temperature sensing for thermal measurements | Medical technology | Solta Medical Ireland Limited |
| Sep 16, 2025 | D1,093,609 | Tip for a medical device | | Solta Medical Ireland Limited |
| Sep 9, 2025 | D1,092,753 | Tip for a medical device | | Solta Medical Ireland Limited |
| Apr 29, 2025 | 12,285,414 | Methods of treating hepatic encephalopathy | Medical technology | Salix Pharmaceuticals, Inc. |
| Mar 18, 2025 | 12,251,152 | Ceramic applicator for transcutaneous delivery of energy | Medical technology | Solta Medical Ireland Limited |
| Dec 24, 2024 | D1,055,301 | Light therapy device | | Solta Medical Ireland Limited |
| Dec 3, 2024 | 12,156,688 | Microblade structure and method of treating tissue | Medical technology | Solta Medical Ireland Limited |
| Nov 19, 2024 | 12,146,003 | Ultra-pure agonists of guanylate cyclase C, method of making and using same | Biotechnology | Bausch Health Ireland Limited |
| Nov 12, 2024 | 12,138,278 | Topical compositions | Pharmaceuticals | Bausch Health Ireland Limited |
| Nov 5, 2024 | 12,133,859 | Topical compositions | Pharmaceuticals | Bausch Health Ireland Limited |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 4, 2025 | 2025/0367175 | Solid Dispersion Forms of Rifaximin | Pharmaceuticals | Salix Pharmaceuticals, Inc. |
| Nov 20, 2025 | 2025/0352569 | TOPICAL COMPOSITIONS | Pharmaceuticals | Bausch Health Ireland Limited |
| Aug 14, 2025 | 2025/0255895 | TOPICAL COMPOSITIONS | Pharmaceuticals | Bausch Health Ireland Limited |
| Jul 17, 2025 | 2025/0228828 | METHODS OF TREATING HEPATIC ENCEPHALOPATHY | Medical technology | Salix Pharmaceuticals, Inc. |
| May 29, 2025 | 2025/0171497 | ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME | Biotechnology | Bausch Health Ireland Limited |
| May 1, 2025 | 2025/0138309 | DEVICES FOR APPLYING ELECTROMAGNETIC ENERGY WITH PRISMATIC BEAM STEERING | Medical technology | SOLTA MEDICAL IRELAND LIMITED |
| Mar 13, 2025 | 2025/0082616 | Solid Dispersion Forms of Rifaximin | Pharmaceuticals | Salix Pharmaceuticals, Inc. |
| Feb 13, 2025 | 2025/0049881 | FORMULATIONS OF GUANYLATE CYCLSE C AGONISTS AND METHODS OF USE | Pharmaceuticals | Bausch Health Ireland Limited |
| Jan 16, 2025 | 2025/0017854 | TOPICAL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES | Pharmaceuticals | Bausch Health Ireland Limited |
| Oct 17, 2024 | 2024/0342142 | METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS) | Pharmaceuticals | Salix Pharmaceuticals, Inc. |
What it applied for, 2024 to 2025: Pharmaceuticals 16 · Medical technology 3 · Biotechnology 2.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.